Medicare Enrolled

Dr. Venkata Marella, MD

Urology Physician · Clifton, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1033 CLIFTON AVE, Clifton, NJ 07013
9734735700
In practice since 2005 (20 years)
NPI: 1083695373 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Marella from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Marella? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Marella

Dr. Venkata Marella is an urology physician in Clifton, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Marella performed 8,669 Medicare services across 5,719 unique beneficiaries.

Between the years covered by Open Payments, Dr. Marella received a total of $2,226 from 36 pharmaceutical and/or device companies across 95 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Marella is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 12% volume in NJ $2,226 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,669
Medicare services
Top 12% in NJ for urology physician
5,719
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~433 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
2,392 $2 $9
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,135 $69 $128
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
805 $8 $25
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
466 $98 $177
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
429 $123 $211
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
321 $104 $226
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
320 $177 $332
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
301 $138 $287
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
296 $60 $106
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
258 $80 $149
Ceftriaxone antibiotic injection
This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered.
242 $0 $24
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
171 $11 $22
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
145 $43 $78
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
117 $18 $39
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
109 $84 $132
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
80 $102 $268
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
78 $106 $620
Transurethral prostate removal with electrocautery
This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding.
74 $570 $991
Complex urodynamic pressure measurement
A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures.
69 $298 $490
Abdominal device insertion with pressure and urine flow study
A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate.
69 $148 $241
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
68 $25 $91
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
68 $242 $466
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
68 $315 $618
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
65 $6 $20
Simple change of bladder tube 52 $73 $125
Bladder instillation of anti-cancer drug
A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue.
45 $69 $135
Injection, garamycin, gentamicin, up to 80 mg 45 $2 $20
Ureteral stone removal via endoscope
A procedure to remove a kidney stone from the ureter using a thin, flexible tube with a camera. The endoscope is inserted to locate and extract the stone.
43 $102 $384
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
43 $90 $168
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
30 $46 $99
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
30 $172 $350
Prostate tissue destruction using radiofrequency heated water vapor
A procedure that destroys prostate tissue by using radiofrequency energy to heat water vapor. This method is applied to treat the prostate gland.
29 $1,285 $2,400
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
29 $44 $84
Complicated insertion of bladder tube 27 $118 $153
Ureteral stent insertion via cystoscopy
A tube is placed into the ureter using an endoscope inserted through the bladder.
27 $60 $510
Shock wave crushing of kidney stones
A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body.
25 $448 $1,136
Bladder and urethra clot removal with endoscope
A procedure using an endoscope to irrigate and remove multiple blood clots from the bladder and urethra.
24 $161 $558
Endoscopic destruction of bladder/urethra growth, less than 0.5 cm
A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters.
18 $606 $1,072
Bladder tumor removal via endoscope
This procedure involves using an endoscope to destroy or remove a large growth from the bladder.
18 $312 $533
Cystourethroscopy with ureteroscopy or pyeloscopy
A diagnostic procedure using an endoscope to examine the bladder, urethra, and ureter or kidney.
15 $200 $427
Endoscopic urethral incision
A procedure where a doctor uses an endoscope to make an incision in the urethra.
12 $173 $386
Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm
This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters.
11 $198 $405
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.8% high complexity
17.4% medium
79.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,226
Total received (2018-2024)
Avg $318/year across 7 years
Top 50% in NJ for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
95
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,939 (87.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$287 (12.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$379
2023
$466
2022
$59
2021
$466
2020
$211
2019
$188
2018
$456

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
COLOPLAST CORP
$77
Dendreon Pharmaceuticals LLC
$60
Teleflex LLC
$56
Boston Scientific Corporation
$42
Astellas Pharma US Inc
$31
Bayer Healthcare Pharmaceuticals Inc.
$27
C. R. Bard, Inc. & Subsidiaries
$26
Telix Pharmaceuticals
$24
Tolmar, Inc.
$18
Merck Sharp & Dohme LLC
$18
Top 3 companies account for 51.0% of 2024 payments
All-time payments by company (2018-2024) ›
Coloplast Corp
$513
Astellas Pharma US Inc
$260
Janssen Biotech, Inc.
$149
Teleflex LLC
$140
COLOPLAST CORP
$90
Antares Pharma, Inc.
$86
Bayer HealthCare Pharmaceuticals Inc.
$75
Dendreon Pharmaceuticals LLC
$75
Endo Pharmaceuticals Inc.
$75
PFIZER INC.
$70
Boston Scientific Corporation
$70
Myovant Sciences Inc.
$53
Clarus Therapeutics Inc.
$40
TOLMAR Pharmaceuticals, Inc.
$40
Merck Sharp & Dohme LLC
$38
ABBVIE INC.
$36
Bioventus LLC
$32
UroGen Pharma, Inc.
$32
Avadel Specialty Pharmaceuticals, LLC
$30
Amgen Inc.
$28
Bayer Healthcare Pharmaceuticals Inc.
$27
C. R. Bard, Inc. & Subsidiaries
$26
Telix Pharmaceuticals
$24
DENTSPLY IH AB
$24
ConvaTec Inc.
$23
CONMED Corporation
$20
Olympus America Inc.
$19
NeoTract Inc.
$19
Tolmar, Inc.
$18
UROVANT SCIENCES INC
$15
Laborie Medical Technologies Corp.
$15
AstraZeneca Pharmaceuticals LP
$15
GlaxoSmithKline, LLC.
$14
Ethicon US, LLC
$13
Allergan Inc.
$12
GENZYME CORPORATION
$11
Top 3 companies account for 41.4% of all-time payments
Associated products mentioned in payments ›
ADVAIR · AIRSEAL · Altis · BOTOX · Bard Urinary Drainage Bag · EDEX · ELIGARD · ERLEADA · EVENITY · Erleada · GEMTESA · GENTLECATH · ILLUCCIX · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LYNPARZA · LoFric · MYRBETRIQ · Myrbetriq · Noctiva · Nubeqa · ORGOVYX · OTREXUP · PROVENGE · SpaceOAR VUE System - 10mL · SpeediCath · Supartz Fx Sodium Hyaluronate · TITAN · Titan · UGN Laser Capital · UROLIFT · UroLift · VISTASEAL · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Clifton?
Compare urology physicians in the Clifton area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
670
Per 100K population
129.3
County median income
$87,137
Nearest hospital
ST JOSEPH'S UNIVERSITY MEDICAL CENTER INC
2.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Marella is a clinical cardiology specialist, with above-average Medicare volume (top 12% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Marella experienced with automated urinalysis?
Based on Medicare claims data, Dr. Marella performed 2,392 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Marella receive payments from pharmaceutical companies?
Yes. Dr. Marella received a total of $2,226 from 36 companies across 95 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Marella's costs compare to other urology physicians in Clifton?
Dr. Marella's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Marella) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →